KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Korsana Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$31.41−0.97 (-3.00%)
Close on Oct 19, 2026
- Market cap
- $133.52M
- P/E (TTM)
- –
- Dividend yield
- –
Korsana Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Market Cap | $147.04M | $197.05M |
| Enterprise Value | $145.65M | $106.56M |
| PS Ratio | 77.39 | 3.93 |
| PB Ratio | 28.91 | 2.14 |
| P/TBV Ratio | 28.91 | 2.46 |
Enterprise value
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| EV / Sales | 76.66 | 2.69 |
Income (trailing twelve months)
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Revenue | $1.90M | $57.94M |
| Operating Income | -$6.82M | -$21.44M |
| Net Income | -$6.71M | -$22.46M |
| EBITDA | -$6.82M | -$16.91M |
| EPS (Diluted) | -$1.68 | -$0.83 |
Margins
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Operating Margin | -359.2% | -44.5% |
| Profit Margin | -353.0% | -39.2% |
| EBITDA Margin | -359.2% | -31.3% |
Returns
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -98.2% | -53.1% |
| Return on Assets (ROA) | -82.3% | -41.0% |
| Return on Invested Capital (ROIC) | -116.4% | -32.0% |
| Return on Capital Employed (ROCE) | -134.1% | -37.8% |
Growth
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -12.6% | 6.01% |
| Revenue Growth (3Y CAGR) | 91.1% | 2.25% |
| Revenue Growth (5Y CAGR) | -2.01% | 6.42% |
Balance sheet
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.39M | $62.42M |
| Net Cash (Debt) | $1.39M | $15.68M |
| Net Cash Per Share | $0.30 | $0.65 |
| Equity (Book Value) | $5.09M | $48.79M |
| Book Value Per Share | $1.09 | $1.36 |
| Tangible Book Value | $5.09M | $23.06M |
| Working Capital | -$329.00K | $75.77M |
Financial position
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Current Ratio | 0.82 | 3.30 |
| Quick Ratio | 0.75 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$4.45M | -$12.35M |
Efficiency
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Asset Turnover | 0.23 | 0.38 |
| Revenue Per Employee | $1.90M | $398.96K |
| Profits Per Employee | -$6.71M | -$732.08K |
| Employee Count | 1 | 73 |
Dividends and yields
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -4.56% | -21.2% |
Shares
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 4,681,350 | 59,128,900 |
| Shares Change (YoY) | 44.9% | 11.1% |
| Shares Change (QoQ) | 0.35% | 0.54% |
Scores
| Measure | Korsana Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | -10.91 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Korsana Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.